Saturday, July 11, 2026

Drug profile · INN

doxil

doxil is a dna inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — doxil
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

doxil is a dna inhibitor.

Key facts

INN doxil
Mechanism DNA inhibitor
Target DNA

Mechanism of action

DNA inhibitor

Primary target: DNA

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  3. azacitidine Antineoplastic and immunomodulating agents (L01)
  4. bleomycin sulfate DNA inhibitor
  5. busulfan Antineoplastic and immunomodulating agents (L01)
  6. capecitabine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is doxil?

doxil is a dna inhibitor.